Hostname: page-component-77c89778f8-swr86 Total loading time: 0 Render date: 2024-07-17T14:01:07.251Z Has data issue: false hasContentIssue false
  • English
  • Français

Peer Comparison of Anti-MRSA Agent Prescription in the Inpatient Setting

Published online by Cambridge University Press:  25 October 2017

Jacqueline T. Bork ,
Daniel J. Morgan ,
Emily L. Heil ,
Lisa Pineles  and
Michael Kleinberg
Jacqueline T. Bork*
Affiliation:
Division of Infectious Diseases, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland
Daniel J. Morgan
Affiliation:
Division of Infectious Diseases, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland
Emily L. Heil
Affiliation:
University of Maryland School of Pharmacy, Baltimore, Maryland.
Lisa Pineles
Affiliation:
Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland
Michael Kleinberg
Affiliation:
Division of Infectious Diseases, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland
*
Address correspondence to Jacqueline T. Bork, 29 S Greene St, Suite 300, Baltimore, MD 21201 (jabork@medicine.umaryland.edu).
Get access Rights & Permissions [Opens in a new window]

Abstract

Peer comparison has potential as an effective antimicrobial stewardship intervention in the inpatient setting. We report a new metric, days of therapy per 100 service days, for comparing antibiotic utilization. Among 14 prescribers on the primary infectious diseases service during a 6-month period, we identified 1 outlier for each anti-MRSA agent.

Infect Control Hosp Epidemiol 2017;38:1506–1508

Type
Concise Communications
Information
Infection Control & Hospital Epidemiology , Volume 38 , Issue 12 , December 2017 , pp. 1506 - 1508
Copyright
© 2017 by The Society for Healthcare Epidemiology of America. All rights reserved 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1. Fridkin, S, Baggs, J, Fagan, R, et al. Vital signs: improving antibiotic use among hospitalized patients. MMWR 2014;63:194–200.Google Scholar
2. Schuts, EC, Hulscher, MEJL, Mouton, JW, et al. Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis. Lancet Infect Dis 2016;16:847–856.Google Scholar
3. Meeker, D, Linder, JA, Fox, CR, et al. Effect of behavioral interventions on inappropriate antibiotic prescribing among primary care practices: a randomized clinical trial. JAMA 2016;315:562–570.CrossRefGoogle ScholarPubMed
4. Heil, EL, Schmalzle, S. eds University of Maryland Medical Center Antibiotic Guidelines. 1st ed. Baltimore; 2016.Google Scholar
5. National Healthcare Safety Network (NHSN) patient safety component manual. Centers for Disease Control and Prevention (CDC) website. https://www.cdc.gov/nhsn/pdfs/pscmanual/pcsmanual_current.pdf. Accessed October 4, 2017.Google Scholar
6. Sievert, DM, Rudrik, JT, Patel, JB, McDonald, LC, Wilkins, MJ, Hageman, JC. Vancomycin-resistant Staphylococcus aureus in the United States, 2002–2006. Clin Infect Dis 2008;46:668–674.Google Scholar
7. van Hal, SJ, Paterson, DL, Lodise, TP. Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter. Antimicrob Agents Chemother 2013;57:734–744.CrossRefGoogle ScholarPubMed
8. Dela-Pena, J, Kerstenetzky, L, Schulz, L, Kendall, R, Lepak, A, Fox, B. Top 1% of inpatients administered antimicrobial agents comprising 50% of expenditures: a descriptive study and opportunities for stewardship intervention. Infect Control Hosp Epidemiol 2017;38:259–265.Google Scholar
9. The Joint Commission. Approved: new antimicrobial stewardship standard. Jt Comm Perspect 2016;36:1–4; The Joint Commission website. https://www.jointcommission.org/assets/1/6/New_Antimicrobial_Stewardship_Standard.pdf%5Cnhttp://www.jcrinc.com/the-joint-commission-perspectives/%5Cnhttps://www.jointcommission.org/assets/1/6/New_Antimicrobial_Stewardship_Standard.pdf. Accessed October 4, 2017.Google Scholar